Page 321 - ILAE_Lectures_2015
P. 321
56 EUROPEAN MEDICINES AGENCY (2010) Guideline on Clinical Investigation of Medicinal Products in the
Treatment of Epileptic Disorders. EMA.
57. CONNOCK, M., FREW, E., EVANS, B.W. et al (2006) The clinical effectiveness and cost effectiveness of newer
drugs for children with epilepsy. A systematic review. Health Technology Assessment 10(7).
58. MARSON, A.G., AL-KHARUSI, A.M., ALWAIDH, M. et al (2007) The SANAD study of effectiveness of
valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised
controlled trial. Lancet 369, 1016–1026.
59. GLAUSER, T.A. (2008) The NIH Childhood Absence Epilepsy Trial: Results from a double-blind randomized
comparative trial. American Epilepsy Society Meeting, 2008.
60. MARSON, A.G., AL KHARUSI, A., ALWAIDH, M. et al (2007) The SANAD Study of efficacy of carbamazepine,
gabapentin, lamotrigine, oxcarbazepine or topiramate for treatment of partial epilepsy: an unblinded randomised
controlled trial. Lancet 369, 1000-1015.
61. LUX, A.L., EDWARDS, S.W., HANCOCK, E. et al (2004) The United Kingdom Infantile Spasms Study comparing
vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre randomised controlled trial. Lancet 364,
1773-1778.
62. LUX, A.L., EDWARDS, S.W., HANCOCK, E. et al (2005) The United Kingdom Infantile Spasms Study (UKISS)
comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a
multicentre randomised trial. Lancet Neurol 4, 712-717.
63. CHIRON, C., MARCHAND, M.C., TRAN, A. et al (2000) Stiripentol in severe myoclonic epilepsy in infancy: a
randomised placebo-controlled syndrome-dedicated trial. Lancet 356, 1638-1642.
64. GUERRINI, R., DRAVET, C., GENTON, P. et al (1998) Lamotrigine and seizure aggravation in severe myoclonic
epilepsy. Epilepsia 39, 508-512.
65. SAITO, Y., OGUNI, H., AWAYA, Y. et al (2001) Phenytoin-induced choreoathetosis in patients with severe
myoclonic epilepsy in infancy. Neuropediatrics 32, 231-235.
66. HANCOCK, E. and CROSS, J.H. (2012) Treatment of Lennox Gastaut syndrome. Cochrane Database Syst Rev,
CD003277.
